Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
US11427604B2 · kind B2 · utility
2Cited by
7References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 2021 |
| Grant date | Aug 30, 2022 |
| Priority date | — |
| Expiry date | Jul 28, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to psilocin derivatives of Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptor in a cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.